Answer
Yes. Its current UK licence covers treating active migraine attacks and preventing migraine in eligible adults.
Sources for this answer
- AQUIPTA 10 mg tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.